Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 27, 2026
Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.
Journal: Clinical pharmacology and therapeutics
Published: March 26, 2026
Anopheles mosquitoes exposed to long-acting antimalarials via drug-supplemented bloodmeal absorb drug but do not suffer fitness costs.
Journal: The Journal of infectious diseases
Published: December 21, 2025
Changing Species Dynamics and Species-Specific Associations Observed between Anopheles and Plasmodium Genera in Diebougou Health District, Southwest Burkina Faso.
Journal: The American journal of tropical medicine and hygiene
Published: December 12, 2025
Effect of pharmacokinetically-relevant ivermectin concentrations on survivorship and fecundity of Anopheles coluzzii and Aedes aegypti in Burkina Faso: A laboratory experimental study.
Journal: PloS one
Published: September 02, 2025
Oncoflash - Research Updates in a Flash!
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 08, 2025
Pixel intensity of wing photos used to infer efficacy of mosquito control interventions against Anopheles gambiae caught during the RIMDAMAL II clinical trial.
Journal: Scientific reports
Published: March 31, 2025
OncoFlash-Research Updates in a Flash!
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 09, 2024
Extended Treatment Duration of Artemether-Lumefantrine in Ugandan Children with HIV on Efavirenz-Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic Trial.
Journal: Journal of clinical pharmacology
Published: November 08, 2024
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.
Journal: The Lancet. Infectious diseases
Published: August 23, 2024
Last Updated: 09/26/2026